key: cord-0774641-3keigb89
authors: Undelikwo, V. A.; Shilton, S.; Folayan, M. O.; Alaba, O.; Ivanova Reipold, E.; Martinez-Perez, G.
title: COVID-19 self-testing in Nigeria: Stakeholders opinions and perspective on its value for case detection
date: 2022-01-29
journal: nan
DOI: 10.1101/2022.01.28.22269743
sha: 8e47fb92ac6e1bfa841763a0ae1fb2f155bf2855
doc_id: 774641
cord_uid: 3keigb89

Background COVID-19 testing coverage is limited in Nigeria. Access to SARS-CoV-2 self-testing kits may help improve the detection of asymptomatic and mildly symptomatic cases and increase the currently low rate of COVID-19 testing in the country. Before implementing SARS-CoV-2 self-testing in Nigeria, it is imperative to assess the populations perceptions regarding this innovation. We therefore conducted a qualitative study to investigate peoples values and preferences for SARS-CoV-2 self-testing in Nigeria. Methods We used semi-structured interviews and focus group discussions among healthcare workers, community representatives, and public health implementors to explore values and perceptions around various aspects of COVID-19 testing, including conventional COVID-19 testing, SARS-CoV-2 self-testing, the safe and effective use of SARS-CoV-2 self-testing, actions upon receiving a positive SARS-CoV-2 self-test result, and future prospects for SARS-CoV-2 self-testing. Results Respondents reported that there is limited availability of conventional SARS-CoV-2 testing in Nigeria. While just a few respondents were familiar with SARS-CoV-2 testing, respondents generally supported the use of SARS-CoV-2 self-testing as they felt it could assist with early case detection and improve access to testing. Concerns relating to the use of SARS-CoV-2 self-testing were majorly about the ability among low literacy populations to use and interpret the test, the affordability of tests, equity of access, and the availability of healthcare system support for those who test positive. Conclusion Though the public perceive multiple benefits associated with access to SARS-CoV-2 self-testing, the efficiency of the national health service delivery system may limit access of the users of the kits to psychosocial and clinical support. In Nigeria, where COVID-19 vaccine coverage is low and the risk of further waves of COVID-19 is high, self-testing may assist in the prompt detection of cases and contribute to halting the spread of the virus.

Introduction 43

Coronavirus disease 2019 (COVID-19) is a novel disease that has caused a global pandemic, 44 resulting in more than 332 million infections and 5.5 million deaths in January 2022 (1). It is an 45 airborne, respiratory infection that is easily transmissible between individuals. Although vaccines 46 against COVID-19 can reduce the severity of infection, they do not eliminate the risk of infection or 47

transmission of the infection (2). There is a need for sustainable COVID-19 containment strategies to 48 halt its transmission, especially in low-and middle-income countries (LMICs), where COVID-19 49 vaccine coverage remains low and the risk of multiple further waves of the pandemic is high (3). 50

One effective strategy to help contain COVID-19 is community-wide testing to enable prompt 51 detection of cases. The most accurate technology for the detection of SARS-CoV-2, real-time reverse 52 transcription polymerase chain reaction (RT-PCR), can determine whether a person is currently 53

infected with SARS-CoV-2 (4). However, LMICs have few RT-PCR-equipped laboratories, and 54 limited resources to provide essential reagents (5). To facilitate community-level case identification, 55 rapid antigen tests, in the form of lateral flow assays, represent a low-cost, portable, and easy-to-56 perform solution for LMICs, although they are less sensitive than RT-PCR. Multiple asymptomatic 57

cases of COVID-19 may go undetected (6). To reduce this risk, self-tests for serial or frequent home-58 use enable people to test self-collected specimens and detect SARS-CoV-2 infection without the 59 direct assistance of healthcare professionals (7, 8).

While not yet widely introduced in most LMICs, 60 the commercialization and distribution of SARS-CoV-2 self-tests has already been approved across 61

Canada (8), the United States (9), and India (10). 62

In some LMICs, self-administered rapid HIV, malaria, and syphilis tests are already widely used (11-63 15) . The World Health Organization (WHO) has recently released recommendations for hepatitis C 64 self-testing (16). The acceptability of self-testing among the general population is usually high, as 65 these approaches can help to ensure higher levels of confidentiality, they are usually more affordable 66 and accessible, and they guarantee freedom of choice of testing location (13, 17). As with other self-67 testing devices, self-testing for SARS-CoV-2 may be a feasible solution to resource-constrained 68 governments' lack of capacity to carry out mass screening for COVID-19, provided there are clear 69 pathways to ensure self-testing users can access treatment and can isolate when needed. 70

In Nigeria, the country in West Africa worst affected by the COVID-19 pandemic (18), the concept 71 of individuals having access to technologies for self-testing for infectious diseases is not new. The 72 acceptability of HIV self-testing is high (19-21), although its use is not yet widespread, and so is the 73 acceptability of malaria self-testing by the general public (22) and healthcare workers (23). Access to 74 SARS-CoV-2 self-testing kits may help increase the prompt detection of infection in asymptomatic 75 and mildly symptomatic cases and improve the currently low rate of COVID-19 testing in the 76 country (24). It could also reduce the resistance to seeking care that results from the stigma 77 associated with COVID-19 infection (25). 78

To develop and issue recommendations for regulatory and public health practice around SARS-CoV-79 2 self-testing in Nigeria, it is imperative to conduct a thorough assessment of the population's 80

perceptions regarding the innovation, as this can provide insights into socio-culturally acceptable 81 strategies for implementing self-testing, helping to address any barriers and accelerating its 82 widespread use. We therefore conducted a qualitative research study to investigate the values and 83

preferences of the general population around SARS-CoV-2 self-testing in Nigeria. 84

Methods 85 . CC-BY-NC-ND 4.0 International license It is made available under a is the author/funder, who has granted medRxiv a license to display the preprint in perpetuity. (which was not certified by peer review)

The copyright holder for this preprint this version posted January 29, 2022. ; https://doi.org/10.1101/2022.01.28.22269743 doi: medRxiv preprint Values of COVID-19 Self-testing in Nigeria 4

For this qualitative inquiry we used semi-structured interviews (SSIs) and focus group discussions 87

(FGDs). The study was conducted in Nigeria by the Institute of Public Health, Obafemi Awolowo  88  University, Ile-Ife with the support of FIND. This was an ancillary study to a larger, population-89  based survey conducted in Nigeria between July and September 2021, which assessed the general  90 public's values and acceptance around SARS-CoV-2 self-testing (hereafter referred to as "self-91

testing") (26). 92

The study population comprised three groups of stakeholders who hold decision-making capacities 94 for the future usage of self-testing. Healthcare workers (HCWs) were targeted because of their 95 capacity to recommend (or not recommend) the use of self-testing to their patients. Representatives, 96 or spokespersons, of various civil society communities (RCSs) were targeted because of their 97 capacity to influence community decision-making on the utility of self-testing and guide people on 98 what to do following a reactive self-test result. Potential COVID-19 self-testing implementers (PIs) 99

were targeted because of their capacity to decide to pool financial and human resources to procure 100 and distribute self-testing at scale, for example in the workplaces they managed or in the geographies 101

where they had jurisdiction to regulate or operate. Common inclusion criteria for all populations 102

were: aged 18 years or more, willing to provide informed consent, and fluent in English or could 103 communicate in broken English. 104

Efforts were made to ensure maximum variation in sampling in terms of gender, urban and rural 105 workplaces, and professional and institutional profiling. To ensure a diversity of voices was 106 represented in the sample, a purposive sampling approach was used. Sex-disaggregated lists of at 107 least 50 profiles per study population were produced. To avoid sampling by convenience, these lists 108 were randomly rearranged by FIND staff using the RANDOM.Org ® randomizer. The interviewers 109 contacted potential informants by phone, starting with the first name on each list. Potential 110 informants were provided with information about the study's aim and procedures, and those who 111 expressed an interest in participating were asked to partake in either an SSI or an FGD. 112

All informants gave their informed consent. Depending on the informants' expressed preferences, 114 data collection was conducted either using Zoom ® teleconferencing software or in-person at a 115 designated place convenient for the informant and the interviewer. Each informant chose the 116 language in which the interview was to be conducted. 117

The data collection was led by a team of research assistants with qualitative research experience. The 118 same 45-item structured guide was used for SSIs and FGDs. The guide included questions around six 119 main topics: knowledge of conventional COVID-19 testing; values around self-testing; the public's 120 preferences for the delivery of self-testing; safe and effective use of self-testing; actions taken upon 121 receiving a reactive self-test result; and future prospects for the distribution of self-tests (26). The 122

interviewers posed the 45 questions to the informants in the same order and probed them further 123

depending on the nature of their responses. 124

All encounters were audio-recorded. Zoom ® encounters were not video-recorded. The recordings 125

were transcribed verbatim into MS-Word ® files. Responses not in English were translated into 126 . CC-BY-NC-ND 4.0 International license It is made available under a is the author/funder, who has granted medRxiv a license to display the preprint in perpetuity. (which was not certified by peer review)

The copyright holder for this preprint this version posted January 29, 2022. ; https://doi.org/10.1101/2022.01.28.22269743 doi: medRxiv preprint English. All transcripts and translated sections within the transcripts were cross-checked by the 127 analysts (VAU, OA, MOF) against the recordings, for accuracy and completeness. 128

Transcripts were uploaded into Quirkos ® software, and a thematic comparative analysis was applied. 130 First, all transcripts were deductively coded using a pre-defined coding scheme (26). Whenever an 131 emerging theme was identified, new codes were inductively created. In parallel with the coding, the 132 analysts prepared reflexive memos to control for the risk of informant bias. 133

Iteratively with the coding, the dataset was analyzed using a four-stage approach: Transcript by 134 transcript at first; followed by a theme-by-theme, sex-sensitive comparison of coded narratives across 135 all transcripts and then by a theme-by-theme rural versus urban-sensitive comparison of coded 136 narratives across all transcripts; and finishing with a trans-study population comparison of key 137 findings. 138

The reports were prepared taking into consideration general insights as well as insights from isolated 139 or deviant cases. The informants' own words were used to prepare the report. Attention was paid to 140 the memos to ensure that no analysts' informant biases were being introduced. The findings are presented as per the four core themes included in the analysis process, namely: 162 uptake of conventional COVID-19 testing; values around SARS-CoV-2 self-testing; safe and 163 effective use of self-testing; and future prospects for the delivery of self-testing. Unless otherwise 164 specified, the voices reported below were common across the three study populations. 165

. CC-BY-NC-ND 4.0 International license It is made available under a is the author/funder, who has granted medRxiv a license to display the preprint in perpetuity. (which was not certified by peer review)

The copyright holder for this preprint this version posted January 29, 2022. ; https://doi.org/10.1101/2022.01.28.22269743 doi: medRxiv preprint Access to conventional facility-based testing was described as being of most interest to travelers and 167 symptomatic patients. Testing was not considered to be in great demand for case detection among 168 mildly symptomatic people. Several deterrents to testing for the general public were identified, 169

including the high cost, frequent delays to receive test results, a generalized perception that COVID-170 19 was low-risk, and a fear of isolation and being "stigmatized". Walk-in visits to health facilities to 171 demand testing by members of the community was described as limited because communities were 172 perceived as either "poorly educated" about COVID-19 symptoms, lacking in "motivation" to 173 request tests, or were unable to afford them. 174

It has to do with the early stigmatization. Once someone is tested positive to HCWs noted that the detection of early infections is difficult as most people present to health 185 facilities at an advanced stage of the disease. Additionally, all study groups perceived there to be a 186 dearth of clinic-or laboratory-based testing sites. Most HCWs expressed that they were not involved 187

with COVID-19 testing and emphasized that the scarcity of diagnostic centers, together with facility 188 staff being too busy caring for patients, limit the healthcare system's capacity for community-based 189 case detection. The shortage of trained professionals to conduct COVID-19 testing, poor availability 190 of COVID-19 diagnostics, and limited access to personal protective equipment were other limiting 191 factors for the routine testing of symptomatic patients and their contacts. The RCSs also mentioned 192 language barriers, lack of privacy, poor safety, and low wages as barriers for healthcare workers to 193 conduct community-based testing. 194

All informants who had direct (e.g., collection of nasal or blood samples) or indirect (e.g., being a 195 member of the State's COVID-19 committee) experience of testing resided or worked in an urban 196 area. None of the informants from rural areas reported any type of experience with COVID-19 testing 197 and hence, as many of them reflected, lacked factual knowledge in relation to testing sites, 198

techniques, and operators. While the HCWs were aware that COVID-19 could be diagnosed using 199 rapid antigen testing, many RCSs and PIs could not explain in any detail what diagnostic 200 technologies for COVID-19 were available in their contexts. 201

Of all the informants, just three HCWs were aware of self-testing. They had learned about it through 203 the social media, CNN and Al Jazeera, and an international journal. Despite the general lack of 204 knowledge around self-testing, most informants had an opinion on its potential advantages. Self-205

testing was perceived to be an innovation that would help end-users reduce costs, time, and other 206 resources necessary to access COVID-19 diagnostic centers. It was defined as a potentially private, 207 convenient, and easy way to obtain a prompt diagnosis of SARS-CoV-2 infection, to facilitate access 208

to early treatment and, as a consequence, to reduce COVID-19-attributable mortality. It was also 209 . CC-BY-NC-ND 4.0 International license It is made available under a is the author/funder, who has granted medRxiv a license to display the preprint in perpetuity.

The copyright holder for this preprint this version posted January 29, 2022. ; https://doi.org/10.1101/2022.01.28.22269743 doi: medRxiv preprint noted, especially by the HCWs, that the workload and "stress" among health facility personnel would 210 be reduced. Special emphasis was placed on the assertion that the confidentiality of self-testing 211 results would help some end-users overcome their fear of stigma: 212

One advantage is it will make the detection of the disease very easy, because it could actually serve 213 as a facilitator because people will prefer to do the test themselves in the comfort of their homes 214

instead of going out to health facility and then everybody starts looking at them and thinking that 215

"does this person have COVID-19 or not?" (SSI 5, rural female RCS) 216

Some potential disadvantages, more related to the idea of self-testing among specific end-users than 217

to the technology itself, were also identified. As per the informants' narratives, some end-users, 218 especially populations with low levels of literacy, may be less able to correctly interpret the results. 219

The possibility of obtaining invalid results due to poor compliance with the test's instructions was 220 also frequently mentioned. It was suggested that some end-users may self-medicate or may deny a 221 positive result and thus refuse to seek medical treatment. 222

Although there was consensus that the availability of self-testing in Nigeria may improve public 223 interest in COVID-19 testing, it was also suggested that it would be mainly travelers who may prefer 224

to use self-testing to avoid the "stress of doing a PCR", that the "elites" would be among the first to 225 use them as they have more information and resources to obtain them, and that urban dwellers will 226

show more interest in self-testing than their rural counterparts. The HCWs further perceived that 227

various cadres of healthcare professionals may themselves benefit from the regular use of self-testing 228

if they are exposed to COVID-19 in the workplace. 229

The majority of informants stated they would recommend self-testing as they considered it could lead 230 to early commencement of treatment for those who might need it, and of measures to avoid further 231 transmission of the virus. Some HCWs also expressed that they would be keen to recommend self-232

testing to their communities, as this could help alleviate their daily workload in healthcare facilities. 233

The informants' likelihood of recommending self-testing, however, might also be influenced by 234 factors such as price, ease of use, availability, and accuracy. To tackle the likely barrier of unaffordability for a large proportion of the Nigerian populace, a few 246

PIs and all RCSs opined that self-testing kits should be delivered free-of-charge. Conversely, some 247

HCWs, PIs, and RCSs opposed the free distribution of kits on the premise that the public "do not 248

value what is free". If the devices had to have a market price, the preferred maximum cost expressed 249 by RCSs and PIs was Naira (N) 250 and N500, respectively (N100 is approximately US$0.25). 250

HCWs held the most varied views, with some suggesting pricing ranging between N100 and N500 251 and others suggesting pricing ranging between N1000 and N2500. 252 . CC-BY-NC-ND 4.0 International license It is made available under a is the author/funder, who has granted medRxiv a license to display the preprint in perpetuity.

The copyright holder for this preprint this version posted January 29, 2022. . CC-BY-NC-ND 4.0 International license It is made available under a is the author/funder, who has granted medRxiv a license to display the preprint in perpetuity.

The copyright holder for this preprint this version posted January 29, 2022. ; https://doi.org/10.1101/2022.01.28.22269743 doi: medRxiv preprint Individuals' non-compliance with isolation following a positive COVID-19 result was not the biggest 295 concern for many of the informants. Some HCWs thought that although some people may use self-296 testing and refuse to disclose a positive result, there was still a likelihood that they would take all 297 possible precautions not to infect others. Other RCSs and PIs opined that some end-users would not 298 report a positive result to a healthcare facility because they would want to manage the disease 299 themselves. One RCS noted that he would simply communicate at work that he was "ill" and would 300 also warn and protect his family members, but he would not report his COVID-19 status. 301

because stigmatization is there too. Once they hear that you are positive for whatever, they will ask 303 you to "Just stay at home and don't even bother to come back again". (FGD 4 with urban HCWs) 304

Individuals who perceive that a positive result "means death" may be at risk of psychosocial ill 305 health, while "resilient" individuals may be more likely to react in way that protects others. The 306

impact of a positive result on an individual will depend on their "personality", level of education, and 307 location of residence. The breadwinners in a household and people with co-morbidities might be 308 particularly concerned about the impact receiving a positive test result might have. To some 309 informants, the "common man" does not perceive COVID-19 to be "fatalistic", and it is mostly the 310 "elites" that are more afraid. Women were thought to be able to react more positively to a positive 311 result than men and young people who, as per some informants' opinions, have generally poorer 312

health-seeking behaviors than women. 313

Irrespective of personal attributes, most informants believed that many individuals might be 314 "psychologically disturbed" after receiving a positive result. The impact might manifest in the form 315 of avoiding people, not going out, becoming "depressed", suffering from insomnia, losing the ability 316 to concentrate, or feeling "lonely" and "afraid of the unknown". 317

which gives some confidentiality. However, the disadvantage is that it can lead to some mental 319 issues, like depression and possibly suicidal tendency if not properly managed. (SSI 23 with urban 320 male PI) 321

There was consensus that a supportive environment may mitigate this impact. If end-users received 322

pre-and post-test counseling, they would be "psychologically prepared" for a positive result. A few 323

HCWs suggested that end-users be counseled on the use of a self-test before receiving it. All groups 324 stressed the need for sustained public education and sensitization through outreach activities and 325 seminars carried out through churches, mosques, social media, and television and radio broadcasts. 326

NGOs/CSOs could play a key role in the dissemination of information at a community-level. A key 327 action to mitigate the risk of psychosocial harm would be to make clear to end-users, in the kits' 328 written instructions, that effective linkage to COVID-19 care will occur should they receive a 329 positive self-test result. 330

All groups expressed the opinion that treatment provision and contact-tracing following an end-user 332 self-reporting in a clinic might be difficult due to a lack of adequate human and logistical resources. 333

To prevent the public becoming disappointed with self-testing, the health sector must be strengthened 334 by increasing the number of staff in healthcare facilities to cater for the volume of clients who might 335 attend for the management of a COVID-19 infection following self-testing. Other steps should 336 include improving health facilities' existing staff capacity to manage cases effectively, irrespective of 337 . CC-BY-NC-ND 4.0 International license It is made available under a is the author/funder, who has granted medRxiv a license to display the preprint in perpetuity.

The copyright holder for this preprint this version posted January 29, 2022. ; https://doi.org/10.1101/2022.01.28.22269743 doi: medRxiv preprint their severity; providing personal protective equipment to all staff tasked with direct management of 338 cases; and increasing the number of facilities closer to the community, where end-users could both 339 report a positive result and receive clinical care. PIs and RCSs identified the need for closer 340 collaboration between healthcare workers and the community, including community development 341

workers, to ensure that users of self-tests receive an appropriate response. 342

Other barriers to be addressed prior to the distribution of self-tests included the possible inability of 343 end-users to afford the kits; anticipated poor distribution and unequal accessibility to the kits 344 throughout the country; poor awareness about the availability of kits; and the likelihood of 345 "hoarding" or stock-outs of self-test kits. To address these barriers, it was proposed that the kits 346 should be rendered affordable through government subsidy, accessible from medical supply outlets in 347 all communities, and introduced to the population following provision of adequate public education. 348

To promote community uptake of self-testing, community mobilization could be sustained using both 349

printed and web-based social media. The "fear of death" should not be used in promotional messages. 350

Rather, public messaging should emphasize "responsibility to care". Some RCSs suggested that 351 acceptability among the public may improve if, during public education efforts around self-testing, 352

the government does not promote any "insinuation" that efforts promoting COVID-19 self-testing are 353

for "ulterior motives" (i.e., in reference to possible suspicions that government officials may be 354 profiting from the introduction of self-testing in their communities). The PIs noted that uptake could 355 be promoted if opportunities for vaccination and treatment were concurrently provided at self-testing 356 distribution points, with simultaneous national policies mandating regular self-testing in work 357 environments. 358

Discussion 359

This study harnessed the opinions of critical stakeholders who would be involved in the rollout of 360 SARS-CoV-2 self-testing in Nigeria. These stakeholders included representatives of communities 361 who might become the potential end-users of self-testing; healthcare workers who might advise 362 community members on self-testing access and usage; and implementers from the private and public 363 sectors who have access to resources, make decisions in relation to the rollout of self-testing, and are 364 in a position to support the country's continued access to self-testing kits and post-testing care. There 365 was consensus across all three groups that self-testing would be of considerable value in helping to 366 overcome some of the current individual-, health system-, and community-level barriers to ensure 367 access to and benefit from conventional healthcare facility-based COVID-19 testing. Nevertheless, 368 the uptake and use of self-testing was not perceived to be free of challenges. To overcome any 369 potential risks associated with the misinterpretation of results, misuse of kits, or under-reporting of 370 reactive results, the informants also proposed strategies to promote the uptake of self-testing in a 371 viable way and to guarantee counseling and healthcare provision to those whose self-test result is 372 positive for SARS-CoV-2. 373 One of the values of self-testing identified by our informants was that it may reduce the burden on 374 overstretched healthcare facilities. Self-testing offers opportunities for asymptomatic individuals or 375 those with a mild case of infection to either rule out the possibility of having a SARS-CoV-2 376 infection or to seek care only in the event of a reactive result. In any case, plans must be instituted to 377 accommodate a likely increase in the number of self-testers that may visit their nearest clinic 378 requesting confirmatory testing and specialist care. The risk of further burdening the healthcare 379 system can be reduced if plans are made to scale-up facilities' capacity to respond to any increase in 380 self-test-diagnosed cases prior to any rollout of self-testing. 381 . CC-BY-NC-ND 4.0 International license It is made available under a is the author/funder, who has granted medRxiv a license to display the preprint in perpetuity.

The copyright holder for this preprint this version posted January 29, 2022. ; https://doi.org/10.1101/2022.01.28.22269743 doi: medRxiv preprint Some of the structural barriers identified for facility-based COVID-19 testing, such as the cost of 382 healthcare, unavailability of diagnostics and therapies, and rejection of the "diseased" by certain 383

sections of the public, might affect the uptake of self-testing if left unaddressed. The cost of 384 healthcare already hampers the uptake of and adherence to HIV services (27) and preventive care 385 (28), and it is a critical consideration for provision of laboratory services (29). The informants 386

suggested that self-testing devices should be subsidized, although concern was expressed by some 387 that the cost of isolation might be a greater worry than the cost of self-testing. 388

Concerns about "hoarding" and stock-outs were expressed in our study. For future implementation of 389 self-testing, it will be important to identify which distribution and accountability models will be the 390 most cost-effective in making self-testing available (and affordable) in areas where the communities 391 have concerns regarding the governance of health product supplies. As hinted by some informants, 392

NAFDAC could make a key contribution, by passing stringent regulations on self-test distribution 393

and quality assurance, to mitigate the risk of unavailability of quality self-test kits throughout 394

Nigeria. 395

In determining the most cost-effective models for the distribution of self-tests, other emotion-related 396 factors interact with cost and the regulatory framework. The psycho-emotional burden of receiving a 397 positive self-test result must also be considered. As with HIV infection, COVID-19 infection is 398 associated with stigma (30), which implies that for distribution models to be cost-effective they must 399 include provisions to mitigate the fear of being stigmatized for having COVID-19 and, as a 400

consequence, incurring social and economic loss or deprivation. In the absence of provision of 401 psychosocial support and clear pathways for linkage to post-self-test care, even the best distribution 402 models may fail. Our study emphasizes the need for pre-and post-self-test counseling provision, as 403

well as for the engagement of various stakeholders from the public and private not-for-profit 404

healthcare provision sectors, to support provision outside of the regular healthcare system. 405

The stress associated with the possibility of isolation must be acknowledged and addressed as one of 406 the most impactful impediments to testing as a whole, professional use or self-test. This is a 407 reasonable concern for many men who are burdened with the need to provide care for their family as 408 the sole bread winner in many households, as well as for many women who work in the informal 409 economy and rely on their daily wages to provide for their children (31). In a country with sections of 410 the population severely affected by high rates of malnutrition and extreme poverty, a debate is 411 urgently needed on which measures would be the most effective, and acceptable to both society and 412

health authorities, to ensure that people who are infected who cannot isolate will not transmit SARS-413

CoV-2 to others. 414

Isolation seemed to be a greater concern than fear of morbidity. This study did not provide an 415 understanding on why there might be a low perception of risk (i.e., individuals' judgments about and 416 evaluations of hazards to which they may be exposed) for COVID-19 disease among some Nigerians 417 though a prior study has made some suggestions. This low perception of risk is also a barrier to the 418 use of self-testing. Nevertheless, what this study has identified is the need to tailor appropriate risk 419 communication and education to enable individuals to understand their risks (32), when resorting to 420 malaria treatment in the absence of either a malaria or a COVID-19 test, or self-managing a COVID-421 19 infection without having at least warned their relatives and other close contacts. 422

Gender norms are another structural factor that cannot be transformed in the short-term and that may 423 affect self-testing usage. Self-testing distribution models must include targeted strategies to 424 encourage the uptake of self-testing by men and adolescents who, as per our respondents' voices, are 425 . CC-BY-NC-ND 4.0 International license It is made available under a is the author/funder, who has granted medRxiv a license to display the preprint in perpetuity.

The copyright holder for this preprint this version posted January 29, 2022. ; https://doi.org/10.1101/2022.01.28.22269743 doi: medRxiv preprint perceived to exhibit limited use of health services or to be persons with worse healthcare behaviors 426 than women. Lessons on entry strategies for self-testing may, therefore, be learned from the 427 introduction of HIV self-testing that specifically targeted men (19). 428

Our study has some strengths and limitations that should be considered. The informants were 429 recruited from both urban and rural areas of Nigeria, and diversity regarding gender identities, 430 location of work, and socio-professional profiles was ensured. However, this was a qualitative study, 431 and the informants' insights may not be representative of all possible opinions in the country. Our 432 findings offered themes and insights that might be characteristic of the specific groups represented in 433 our sample. Additionally, some data collection encounters were carried out via Zoom ® . The content 434 of interviews conducted online and in-person was similar; however, the interviewers felt that it was 435 easier to build rapport with the interviewees when partaking in face-to-face encounters. The 436 possibility that informants interviewed via Zoom ® changed their narratives due to privacy or 437 confidentiality concerns cannot be disregarded. 438

In conclusion, facilitating the adoption and use of self-testing in Nigeria will require multiple layers 439 of planning, ranging from the active engagement of policymakers to develop regulations and 440 strategies for the rollout of a national self-testing program, to capacity-building of health institutions 441

to manage the increased demand that may result from the rollout, and to the active engagement of 442 communities and community decision-making platforms to allay fears and to support and promote 443 the effective use of self-testing. While the public may perceive that access to SARS-CoV-2 self-444 testing will be beneficial in the long-term, the structures and systems in health care institutions must 445 be prepared to provide appropriate psychosocial and clinical support to self-testers. For a populous 446 country like Nigeria, where COVID-19 vaccine coverage remains low and the risk of further 447 epidemic waves of COVID-19 is looming, self-testing holds promise for allowing communities 448 themselves to promptly detect cases and contribute to halting the spread of the virus in the region. 449

The authors declare that this research was conducted in the absence of any commercial or financial 451 relationships that could be construed as a potential conflict of interest. design; in the collection, management, analysis, or interpretation of the data; in writing the report; or 460

in the decision to submit the report for publication. 461

Acknowledgments 462

The authors are greatly indebted to all informants who agreed to participate in this study and to share 463 their insights with us. This article has been submitted as a pre-print on medRxiv. 464 . CC-BY-NC-ND 4.0 International license It is made available under a is the author/funder, who has granted medRxiv a license to display the preprint in perpetuity.

The copyright holder for this preprint this version posted January 29, 2022. . CC-BY-NC-ND 4.0 International license It is made available under a is the author/funder, who has granted medRxiv a license to display the preprint in perpetuity. (which was not certified by peer review)

The copyright holder for this preprint this version posted January 29, 2022. 

. CC-BY-NC-ND 4.0 International license It is made available under a is the author/funder, who has granted medRxiv a license to display the preprint in perpetuity. (which was not certified by peer review)

The copyright holder for this preprint this version posted January 29, 2022. ; https://doi.org/10.1101/2022.01.28.22269743 doi: medRxiv preprint

World Health Organization. Coronavirus disease (COVID-19) pandemic Geneva: World 466 Health Organization

World Health Organization. WHO Director-General's opening remarks at the media briefing 473 on COVID-19 -11

COVID-19 diagnosis -A review of current methods

Charting the challenges behind the testing of COVID-19 in developing 479 countries: Nepal as a case study

Prevalence of Asymptomatic SARS-CoV-2 Infection : A Narrative 481 Review

A decentralised 483 point-of-care testing model to address inequities in the COVID-19 response

Syphilis Self-testing: A 506 Nationwide Pragmatic Study Among Men Who Have Sex With Men in China

World Health Organization. Recommendations and guidance on hepatitis C virus self-testing: 509 web annex D: values and preferences on hepatitis C virus self-testing. Geneva: World Health 510 Organization

Acceptability 512 and Usability of HCV Self-Testing in High Risk Populations in Vietnam

Cross-515 national variations in COVID-19 outbreak in West Africa: Where does Nigeria stand in the 516 pandemic? Spatial Information Research

Uptake and Intervention Strategies Among Men in Sub-Saharan Africa: A Systematic Review. Front 519 Public Health

Acceptability 521 and correlates of HIV self-testing among university students in northern Nigeria

Population Council. Feasibility and acceptability of HIV self-testing among men who have 526 sex with men in Nigeria

Assessing Acceptability of a Diagnostic and Malaria Treatment Package Delivered by Community 530

World Health Organization. Social stigma threatens COVID-19 response but patients heal 535 faster with everyone's support Geneva: World Health Organization

Assessing Values and 539 Preferences Toward SARS-CoV-2 Self-testing Among the General Population and Their 540

Health Care Personnel, and Decision-Makers: Protocol for a Multicountry Mixed 541 Methods Study

The impact of 543 user fees on uptake of HIV services and adherence to HIV treatment: Findings from a large HIV 544 program in Nigeria

Preventive healthcare uptake in private 546 hospitals in Nigeria: a cross-sectional survey (Nisa premier hospital)